Insider filing
Traded Apr 1 · filed 1 day later
Routine share withholding; mechanical by default.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Mar 9, 2026 · Filed Mar 11, 2026
Axon Enterprise's CHIEF REVENUE OFFICER sold $690K of Axon Enterprise shares. The filing says it was made under a pre-arranged trading plan.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market sale
Code S — open-market or private sale
~$690,488
Shares × reported transaction price
13 days after results of Feb 24, 2026, 58 days before results of May 6, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $559.06 on Mar 9, 2026, 40% above its 52-week low and 36% below its high, after a 9% drop over the previous 30 trading days
52-week range $399.65 (Feb 5, 2026) to $870.97 (Aug 7, 2025), 34% of the way up, from 251 adjusted closes. 30 trading days earlier: $613.14 on Jan 23, 2026. Describes the past only, not a forecast
RSI 60, 16% under its 200-day average, 4% above its 50-day average, 36% below the 52-week high, 20-day volatility 70% a year, against the S&P 500: +40 points over 1 month, +2 points over 3 months, −28 points over 6 months
From the adjusted closes up to Mar 9, 2026. RSI: Wilder's 14-day relative strength index (0 to 100). Averages: the last 50 and 200 closes. Volatility: standard deviation of the last 20 daily returns, annualised. S&P 500: the stock's move minus SPY's between the same dates (21, 63 and 126 trading days). Describes the past only, not a forecast
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
A securities lawsuit naming the company as a defendant was filed on Feb 17, 2026 in the U.S. District Court, District of Columbia. A filing is an allegation, not a finding.
NATHAN CUMMINGS FOUNDATION, INC. v. AXON ENTERPRISE, INC., docket 1:26-cv-00501, via CourtListener (court records). Nature of suit 850, company named as first defendant
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +0.6% | −0.9% | +1.5% |
| 30 days | −28.0% | +3.0% | −31.0% |
| 90 days | −10.4% | +8.9% | −19.3% |
| 180 days | +1.2% | +15.0% | −13.8% |
Past results only. Not a forecast.
Insider filing
Traded Apr 1 · filed 1 day later
Routine share withholding; mechanical by default.
Jeri Williams (Director) sold ~$77K of Axon Enterprise
Planned saleInsider selling
Traded Mar 17 · filed 1 day laterNot reported under a pre-arranged trading plan
An Axon Enterprise director sold $100K of Axon Enterprise shares. The filing does not indicate a pre-arranged trading plan.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.